Publications of the MPI of Experimental Medicine until 2021
Journal Article (94)
1.
Journal Article
9 (1), 201 (2014)
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases 2.
Journal Article
107 (11), pp. 2693 - 2699 (2014)
Mechanics of individual keratin bundles in living cells. Biophysical Journal 3.
Journal Article
24 (6), pp. 374 - 387 (2014)
Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Therapeutics 4.
Journal Article
5, 5472 (2014)
Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nature Communications 5.
Journal Article
16 (8), pp. 881 - 888 (2014)
A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. Bipolar Disorders 6.
Journal Article
75 (12), pp. 1347 - 1355 (2014)
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. Journal of Clinical Psychiatry 7.
Journal Article
82 (6), pp. 1209 - 1215 (2014)
Intraventricular craniopharyngiomas: surgical management and outcome analyses in 24 cases. World Neurosurgery 8.
Journal Article
593 (1), pp. 181 - 196 (2014)
Kv10.1 opposes activity-dependent increase in Ca2+ influx into the presynaptic terminal of the parallel fibre-Purkinje cell synapse. J Physiol 9.
Journal Article
95 (5), pp. 535 - 552 (2014)
Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. American Journal of Human Genetics 10.
Journal Article
62 (11), pp. 1749 - 1761 (2014)
Adapting brain metabolism to myelination and long-range signal transduction. Glia 11.
Journal Article
24 (11), pp. 1003 - 1017 (2014)
Selected items from the Charcot-Marie-Tooth (CMT) neuropathy score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. Neuromuscular Disorders 12.
Journal Article
1 (6), pp. 444 - 453 (2014)
Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry 13.
Journal Article
34 (44), pp. 14506 - 14516 (2014)
Annexin A2 regulates TRPA1-dependent nociception. Journal of Neuroscience 14.
Journal Article
34 (44), pp. 14687 - 14696 (2014)
Munc13-3 superprimes synaptic vesicles at granule cell-to-basket cell synapses in the mouse cerebellum. Journal of Neuroscience 15.
Journal Article
9 (10), e110310 (2014)
Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders. PLoS One 16.
Journal Article
9 (3), pp. 902 - 909 (2014)
Secretory vesicle priming by CAPS is independent of the SNARE-bind MUN domain. Cell Reports 17.
Journal Article
84 (2), pp. 416 - 431 (2014)
The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. Neuron 18.
Journal Article
30, pp. 503 - 533 (2014)
Myelination of the Nervous System: Mechanisms and Functions. Annual Review of Cell and Developmental Biology 19.
Journal Article
20 (5), pp. 426 - 431 (2014)
Glial biology in learning and cognition. The Neuroscientist 20.
Journal Article
19 (10), pp. 1143 - 1149 (2014)
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Molecular Psychiatry